Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Reversible graft dysfunction after cardiac transplantation]

J F Obadia1, P Boissonnat, O Bastien

  • 1Service de chirurgie cardio-thoracique A, Hôpital cardiologique, Lyon.

Archives Des Maladies Du Coeur Et Des Vaisseaux
|September 28, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anatomical variations of the renal artery based on the surgeon's direct observation: A French perspective.

Morphologie : bulletin de l'Association des anatomistes·2021
Same author

Evolution of folate biosynthesis and metabolism across algae and land plant lineages.

Scientific reports·2019
Same author

When ethics collides with a legal gap in emergency life-threatening conditions.

British journal of anaesthesia·2018
Same author

Temporary right ventricular support after high-risk tricuspid valve surgery.

International journal of cardiology·2016
Same author

The clover technique in endomyocardial biopsy-induced tricuspid regurgitation.

International journal of cardiology·2015
Same author

Thromboangiitis obliterans - case report.

Chirurgia (Bucharest, Romania : 1990)·2015
Same journal

Radiokymographic study of the kinetics of the middle arc and the hils in the normal subject.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

A medication for angina pectoris and pre-fibrillatory conditions; 1262 F; six years of clinical experience; action mechanism.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Circulatory changes following the injection of hypertonic saline solutions; application to the study of angina pectoris.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Alterations in coronary circulation during aortic insufficiency in young subjects.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Cardio-esophageal auscultation.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Hypertensive accidents following the injection of acetylcholine.

Archives des maladies du coeur et des vaisseaux·2010
See all related articles

Major graft dysfunction after cardiac transplantation can fully recover with biventricular mechanical assistance. This suggests myocardial stunning may cause early graft failure, supporting aggressive management strategies.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Mechanical Circulatory Support

Background:

  • Primary graft failure is a critical complication following cardiac transplantation.
  • Early graft dysfunction necessitates prompt and effective management strategies.

Observation:

  • Three cases of cardiac transplant recipients experienced major graft dysfunction.
  • Patients presented with primary biventricular graft failure and normal preoperative pulmonary resistances.
  • No signs of myocardial infarction or elevated peri-operative enzymes were observed.

Findings:

  • Complete functional recovery of the graft was achieved within 4 to 8 days using biventricular mechanical assistance.
  • The observed early dysfunction aligns with the phenomenon of myocardial stunning.

Related Experiment Videos

  • This suggests a reversible cause for primary graft failure.

    • Implications:

    • Biventricular mechanical assistance is a viable treatment for severe early graft dysfunction.
    • Myocardial stunning should be considered in the differential diagnosis of primary graft failure.
    • Aggressive management approaches are warranted for primary graft dysfunction to improve patient outcomes.